We’ve been getting a lot of questions from our Ovally community on how COVID-19 might affect fertility, as well as access to fertility treatments in the US and in Europe. But before we dive into this content, we’d like to send our heartfelt well-wishes to you, dear readers, and hope you and your loved ones are healthy and safe. For the purposes of this post, we’ll stay focused on fertility; if you’re looking for more detailed information on COVID-19, here’s the latest from the CDC. We’ll keep updating this post as more information becomes available.
Every year, the Center for Disease Control (CDC) publishes statistics on reproductive health, including a small section on patient diagnoses underlying infertility. These diagnoses are based on data from ~260k IVF cycles that were done at 463 fertility clinics in the US (most recently in 2016). Next to “diminished ovarian reserve” (31% of diagnoses), the most common diagnosis women receive has to do with “ovulatory dysfunction”. We at Ovally set out to unpack what that means: